Clinically, PLD3 is closely related to Alzheimer’s disease, and it has been demonstrated to be involved in amyloid precursor protein processing in Alzheimer’s disease pathogenesis (Karch and Goate, 2015; Wang et al., 2015; Fazzari et al., 2017). Here, APP is linked to Alzheimer disease.